Chien Hsing K. Chang
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2006First federal award
$1.3MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $1.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jan 15, 2011 | NIH | SBIR/STTR Phase I Use of milatuzumab in modulating graft vs. host disease | $191K | Immunomedics |
| Sep 1, 2007 | NIH | SBIR/STTR Phase I Novel RNase-based Immunotoxin for CD74-positive B-cell Malignancies | $134K | Immunomedics |
| Sep 29, 2006 | NIH | SBIR/STTR Phase II Dock and Lock: Novel Protein Engineering | $367K | Immunomedics |
| Sep 29, 2006 | NIH | SBIR/STTR Phase II Dock and Lock: Novel Protein Engineering | $521K | Immunomedics |
| Sep 29, 2006 | NIH | SBIR/STTR Phase I Dock and Lock: novel protein engineering | $134K | Immunomedics |
Peer ranks
Federal funding#1,495
Awards as PI#417
Patents#273
Companies
- ImmunomedicsLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.